Even being adjusted by other features, TGFBI (Hazard Ratio = 1.071, 95%CI of ratio: 0.998-1.148, P = 0.049) was still relevant to OS among patients with ccRCC suggested by multivariate Cox analysis (Figure 12B). This evidence concerns the gene TGFBI and nonpapillary renal cell carcinoma.